ZMYND8
Basic information
Region (hg38): 20:47209214-47356889
Previous symbols: [ "PRKCBP1" ]
Links
Phenotypes
GenCC
Source:
- autism spectrum disorder (Limited), mode of inheritance: AD
- neurodevelopmental disorder (Moderate), mode of inheritance: AD
- neurodevelopmental disorder (Strong), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (94 variants)
- not_provided (49 variants)
- ZMYND8-related_disorder (6 variants)
- Neurodevelopmental_disorder (2 variants)
- Intellectual_disability (2 variants)
- ZMYND8-associated_neurodevelopmental_disorder (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZMYND8 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001281775.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | |||||
| missense | 106 | 12 | 120 | |||
| nonsense | 6 | |||||
| start loss | 0 | |||||
| frameshift | 4 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 2 | 2 | 116 | 19 | 4 |
Highest pathogenic variant AF is 6.841499e-7
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ZMYND8 | protein_coding | protein_coding | ENST00000461685 | 23 | 147709 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.00 | 6.08e-8 | 125737 | 0 | 10 | 125747 | 0.0000398 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 4.04 | 399 | 700 | 0.570 | 0.0000419 | 7862 |
| Missense in Polyphen | 80 | 234.01 | 0.34187 | 2776 | ||
| Synonymous | -0.387 | 294 | 286 | 1.03 | 0.0000204 | 2207 |
| Loss of Function | 6.77 | 3 | 59.2 | 0.0507 | 0.00000285 | 719 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000450 | 0.0000439 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.0000980 | 0.0000980 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May act as a transcriptional corepressor for KDM5D. Required for KDM5D-mediated down-regulation of diverse metastasis- associated genes; the function seems to involve the recognition of the dual histone signature H3K4me1-H3K14ac. Suppresses prostate cancer cell invasion. {ECO:0000269|PubMed:27477906}.;
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.0152
- rvis_EVS
- -1.44
- rvis_percentile_EVS
- 3.98
Haploinsufficiency Scores
- pHI
- 0.162
- hipred
- Y
- hipred_score
- 0.731
- ghis
- 0.602
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.999
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zmynd8
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); skeleton phenotype; limbs/digits/tail phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;negative regulation of cell migration;positive regulation of filopodium assembly;positive regulation of dendritic spine development;modulation of excitatory postsynaptic potential;regulation of postsynaptic density protein 95 clustering;positive regulation of dendritic spine maintenance;negative regulation of nucleic acid-templated transcription
- Cellular component
- nucleus;cytoplasm;dendritic spine;dendritic shaft
- Molecular function
- transcription corepressor activity;protein binding;zinc ion binding;protein domain specific binding;methylated histone binding;protein N-terminus binding;repressing transcription factor binding;lysine-acetylated histone binding